| 臺大學術典藏 |
2019-08-29T07:31:54Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:31:54Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Tung-Hung Su;Liao, Sih-Han;Chun-Ming Hong;Chun-Jen Liu;Tseng, Tai-Chung;Chen-Hua Liu;Hung-Chih Yang;Pei-Jer Chen;Ding-Shinn Chen;Chi-Ling Chen;Adhoute, Xavier;Bourli?Re, Marc;Jia-Horng Kao; TUNG-HUNG SU; Liao, Sih-Han; CHUN-MING HONG; CHUN-JEN LIU; Tseng, Tai-Chung; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; Adhoute, Xavier; Bourli?re, Marc; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:30:08Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:30:08Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:29:17Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:29:17Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:28:24Z |
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
|
Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao |
| 臺大學術典藏 |
2019-08-29T07:28:24Z |
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B
|
Yang, Wan-Ting; TUNG-HUNG SU; HUNG-CHIH YANG; CHEN-HUA LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; CHUN-JEN LIU; Chun-Jen Liu;Tseng, Tai-Chung;Yang, Wan-Ting;Tung-Hung Su;Hung-Chih Yang;Chen-Hua Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao |
| 臺大學術典藏 |
2019-08-29T07:26:10Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-29T07:26:10Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
JIA-HORNG KAO;CHI-LING CHEN;DING-SHINN CHEN;PEI-JER CHEN;SHANG-JU WU;HUNG-CHIH YANG;CHEN-HUA LIU;Chou, Shih-Wan;Tseng, Tai-Chung;CHUN-JEN LIU;TUNG-HUNG SU; TUNG-HUNG SU; CHUN-JEN LIU; Tseng, Tai-Chung; Chou, Shih-Wan; CHEN-HUA LIU; HUNG-CHIH YANG; SHANG-JU WU; PEI-JER CHEN; DING-SHINN CHEN; CHI-LING CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:28:14Z |
Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Liang, Cher-Wei;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;Hsu, Cheng-Kai;YI-WEN HUANG; YI-WEN HUANG; Hsu, Cheng-Kai; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Liang, Cher-Wei; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:28:14Z |
Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Liang, Cher-Wei;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;Hsu, Cheng-Kai;YI-WEN HUANG; YI-WEN HUANG; Hsu, Cheng-Kai; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Liang, Cher-Wei; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:20:11Z |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Huang, Shih-Hung;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;YI-WEN HUANG; YI-WEN HUANG; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Huang, Shih-Hung; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-08-05T07:20:11Z |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
JIA-HORNG KAO;Yang, Sien-Sing;PING-NING HSU;PEI-JER CHEN;DING-SHINN CHEN;Huang, Shih-Hung;Chang, Han-Yu;Hu, Jui-Ting;SHU-CHEN WEI;Lin, Shih-Chang;YI-WEN HUANG; YI-WEN HUANG; Lin, Shih-Chang; SHU-CHEN WEI; Hu, Jui-Ting; Chang, Han-Yu; Huang, Shih-Hung; DING-SHINN CHEN; PEI-JER CHEN; PING-NING HSU; Yang, Sien-Sing; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:48:01Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Tseng, Tai-Chung;JIA-HORNG KAO;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;CHEN-HUA LIU; CHEN-HUA LIU; CHUN-JEN LIU; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-02-27T06:44:06Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Tseng, Tai-Chung;Liu, Wen-Chun;Yang, Sheng-Shun;Chang, Chung-Hsin;Yang, Sien-Sing;Huang, Yi-Jie;JIA-HORNG KAO;CHIEN-CHING HUNG;DING-SHINN CHEN;PEI-JER CHEN;CHUN-MING HONG;HUNG-CHIH YANG;TUNG-HUNG SU;CHUN-JEN LIU;HSIN-YUN SUN;CHEN-HUA LIU; CHEN-HUA LIU; Huang, Yi-Jie; Yang, Sien-Sing; Chang, Chung-Hsin; Yang, Sheng-Shun; HSIN-YUN SUN; CHUN-JEN LIU; Liu, Wen-Chun; TUNG-HUNG SU; HUNG-CHIH YANG; CHUN-MING HONG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; CHIEN-CHING HUNG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-10-09 |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-10-09 |
Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus
|
Hung-Chih Yang;Jia-Horng Kao; HUNG-CHIH YANG; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:03Z |
Prevention of mother-to-child transmission: the key of hepatitis B virus elimination
|
Lin, C.-L.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Review article: the prevention of hepatitis B-related hepatocellular carcinoma
|
C.-L. Lin;J.-H. Kao; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
|
Chao-Wei Hsu;Wei-Wen Su;Chuan-Mo Lee;Cheng-Yuan Peng;Wan-Long Chuang;Jia-Horng Kao;Heng-Cheng Chu;Yi-Hsiang Huang;Rong-Nan Chien;Yun-Fan Liaw; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B
|
Chao-Wei Hsu;Wei-Wen Su;Chuan-Mo Lee;Cheng-Yuan Peng;Wan-Long Chuang;Jia-Horng Kao;Heng-Cheng Chu;Yi-Hsiang Huang;Rong-Nan Chien;Yun-Fan Liaw; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:07:02Z |
Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma
|
Ming-Hung Hu;Tzu-Ting Huang;Tzu-I Chao;Li-Ju Chen;Yen-Lin Chen;Ming-Hsien Tsai;Chun-Yu Liu;Jia-Horng Kao;Kuen-Feng Chen; JIA-HORNG KAO |
